Fig. 2From: Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancerKaplan–Meier curves for (A) progression-free survival (PFS) and (B) overall survival (OS). The results presented in the curves refer to the comparison between NACT response (CR + PR) (n = 38) and nonresponse (SD + PD) (n = 10) survival curves. NACT, neoadjuvant chemotherapyBack to article page